Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - EU Market Recap: FTSE 100 +1.08% to 9787.15, DAX +1.65% to 23959.99, CAC40 +1.32% to 8055.51, STOXX 600 +1.42% to 572.82

Nov 10 ,2025

  • Synopsis:

    • European equity markets ended the day higher in a broad-based advance. After initial gains, shares ratcheted higher, ending just below the best levels of the session

    • Sentiment initially aided by news that the US Senate nearing deal to end government shutdown and the US administration's suspension of a probe into China's shipbuilding industry, prompting Beijing to reciprocate. Also, Russia' Lavrov reportedly ready to meet US' Rubio. Wall Street's firmer open supported shares in later trading.

    • Ireland +2.4%, Italy +2.3% and Austria +2.0% led outperformers. Norway +0.4% and Finland +0.6% join the Netherlands and FTSE100 in leading underperformers

    • BOE's Lombardelli delivered opening remarks and chairs a panel at the BOE/Bank of Ghana Pan-African Central Bank Governors' conf . ECB publishes Economic Bulletin pre-release.

    • On politics, EU's von der Leyen participated in a meeting she convenes with the Presidents of the EP and the Presidency of the Council.

    • DIE ZEIT newspaper hosts discussion at 19:00CET with German finance minister Klingbeil on the government's budget, plans for defence spending and compulsory military service, as well as other domestic and international topics.

    • Norway's PM Støre attended a central board meeting of the Labour Party at the party office on Youngstorget. The country's minister of foreign affairs Eide visits China (Mon/Tue) and Singapore (Wed) and minister of labour and inclusion Stenseng spoke at IMDi's annual conf.

    • UN Climate Change Executive Secretary Simon Stiell addressed the official opening of COP30. There's FT Live @ COP 30 through the duration of the Summit.

    • Announcements of the acquisitions of JTC (JTC.LN) and Northern Data (NB2.GR) amongst the M&A news flow, that also included Pandox (PNDX.B.SS) completes acquisition of Dalata Hotel Group, summarises reasons for and financial effects, Blackstone Funds' PUSU deadline to announce firm intention to make an offer for Big Yellow Group (BYG.LN) extended to 8-Dec and PIERER Mobility (PKTM.SW) announces EU Commission does not initiate in-depth investigation under the Foreign Subsidies Regulation into Bajaj Auto International Holdings B.V.'s acquisition of Pierer Industrie's 50.1% stake in Pierer Bajaj. Also, Euronext (ENX.FP) +0.4% lowers acceptance threshold in connection with offer for Hellenic Exchanges-Athens Stock Exchange (EXAE.GA) (0.3%) and Novo Nordisk (NOVO.B.DC) +1.2% decides not to submit a fresh offer for Metsera following Pfizer and Metsera entering into an amended merger agreement

    • Among companies with earnings/update releases are Almirall (ALM.SM) reports 9M net income €41.8M ex-items vs year-ago €9.9M, on track to meet 2025 guidance, Hannover Re (HNR1.GR), LEM Holding (LEHN.SW), Salzgitter (SZG.GR) and Chemring Group (CHG.LN).

    • Reportedly, Siemens (SIE.GR) said to favour direct spinoff of Healthineers (SHL.GR) stake; plans could be announced as soon as next week

    • Elsewhere, HelloFresh (HFG.GR) responds to Grizzly Research short report and Fincantieri (FCT.IM) wins €0.5-1.0B cruise ship order. Reportedly, Renault (RNO.FP) ends rare-earth-free EV motor project with Valeo (FR.FP) as it begins search for alternative, cheaper supplier for its development efforts

  • Digest:

    • Sectors - STOXX Europe 600:

      • Outperformers:

        • Banks +2.87%, Travel & Leisure +2.43%, Basic Resources +1.70%, Retail +1.68%, Ind Goods & Svcs +1.67%, Technology +1.55%

      • Underperformers:

        • Real Estate (0.19%), Telecom (0.12%), Media +0.25%, Utilities +0.37%, Chemicals +0.37%, Food & Beverage +0.78%, Autos & Parts +1.06%, Persnl & HHold Goods +1.09%, Financial Svcs +1.16%, Insurance +1.21%, Oil & Gas +1.37%, Health Care +1.38%, Construct & Mtls +1.41%

    • Macro/Peripheral markets:

      • ECB:

        • ECB prepares leadership overhaul as Lagarde's term ends - FT

        • ECB's interest rates are at the appropriate level barring changes in the economic situation, says de Guindos in an interview - Diário de Notícias

      • EU:

        • Europe and Latin America chart a common course for a fair partnership - CELAC-EU Summit

      • Finland:

        • Minister of Employment Marttinen sets up a working group tasked with identifying solutions to the problems related to online shops focusing on cheap imports; expected to complete its report by Feb-26 - press release

      • Netherlands:

        • Coalition government talks continue, Wed due to see parliamentary vote on mediator's recommendation on how to move forward - Dutch News

      • Russia:

        • Russia's massive strike cripples Ukrainian power grid - Politico

        • Lavrov signals readiness for talks with Rubio - Reuters

        • Kyiv needs to increase its attacks on Russia's oil industry - Chatham House

      • Sweden:

        • Inquiry proposes measures for more efficient expansion of fiber and 5G throughout the country - Govn. press release

        • Government presents a comprehensive approach for even more efficient, robust and more fossil-free and sustainable freight transport - press release

      • UK:

        • Starmer and Reeves face poll meltdown over budget tax betrayal - Express

        • Von der Leyen snubs Starmer over EU payment demands - FT

        • BOE launches consultation on regulating systemic stablecoins - release

          • Role of holding limits for sterling-denominated systemic stablecoins and a potential digital pound - release

          • Proposed regulatory regime for sterling-denominated systemic stablecoins - release

      • Sovereign credit rating reviews after the close Fri included:

        • Ireland AA rating reaffirmed, outlook stable - Fitch

        • Poland

          • A rating reaffirmed, outlook to negative from stable - DBRS

          • A- rating reaffirmed, outlook stable - S&P

    • Company news:

      • Notable Gainers

        • +31.7% NB2.GR (Northern Data) -- confirms Rumble intends to make all-share tender offer for company

        • +24.7% IPH.FP (Innate Pharma) -- announces FDA clearance to proceed with TELLOMAK 3, a confirmatory Phase 3 trial of Lacutamab in CTCL

        • +17.3% WIHN.SW (WISeKey International Holding) -- to publicly list it's subsidiary WISeSat.Space Corp. via business combination with Columbus Acquisition Corp.

        • +17.1% RHIM.LN (RHI Magnesita) -- delivered the expected improvement in performance over 4M from Jul-Oct, in line with FY guidance

        • +15.1% CAMX.SS (Camurus) -- announces positive topline results from Phase 1b study evaluating CAM2056 in comparison to weekly semaglutide in patients overweight or obese

        • +10.0% EMEIS.FP (Emeis SA) --announces agreement in principle for refinancing of bank debt of emeis SA and its subsidiaries Niort 94 and Niort 95

        • +9.0% EYE.LN (Eagle Eye Solutions Group) -- secures five-year contract with large independent North American food retailers

        • +8.3% SMHN.GR (SÜSS MicroTec) -- buy from neutral at UBS; buy from hold at Jefferies

        • +7.4% EAH.LN (Eco Animal Health) -- EMA's CVMP adopts Positive Opinion recommending granting EU marketing authorisation for company's ECOVAXXIN MS

        • +7.2% KRX.LN (Kingspan Group) -- YTD sales +8% y/y to €6.8B; continue to expect to deliver FY trading profit in the region of €950M

        • +7.0% SZG.GR (Salzgitter) -- 9M pretax income (€72.7M) vs consensus (€90M); specifies FY25 guidance in lower half of previous range

        • +6.7% CBK.GR (Commerzbank) -- buy from hold at Deutsche Bank

        • +6.1% OKEA.NO (Okea) -- buy from hold at ABG Sundal Collier

        • +6.1% GNFT.FP (GENFIT) -- presents promising new preclinical data on NTZ/G1090N in the treatment of ACLF; Enters research collaboration with EVerZom to advance exosome-based regenerative technology in ACLF

        • +5.8% ACKB.BB (Ackermans & Van Haaren) -- outperform from neutral at Oddo

        • +5.6% DGE.LN (Diageo) -- appoints Dave Lewis as new CEO

        • +5.2% SOLG.LN (SolGold) -- announces strong drilling results at Tandayama-América

        • +5.0% MPE.LN (M.P. Evans Group) -- expects Group revenue to be higher than previously envisaged, with enhanced anticipated profitability

        • +4.8% BAMI.IM (Banco BPM) -- Unicredit (UCG.IM) considers appeal over BPM golden power ruling -- Repubblica

        • +3.8% HYQ.GR (Hypoport) -- Q3 EPS €0.76 vs year-ago €0.26

        • +3.4% HNR1.GR (Hannover Re) -- Q3 net income €650.8M vs consensus €637M; raises FY net income guidance

        • +2.6% AC.FP (Accor) -- Brookfield and Blackstone looking to acquire Accor's 30% stake in Essendi -- Les Echos

        • +2.3% ENQ.LN (EnQuest) -- signs new $800M senior secured reserve based lending facilities

        • +2.0% STM.GR (Stabilus) -- prelim FY net income €24.2M vs FactSet €35.1M [6 est, €24.8-49M]; expects FY26 to be challenging

          • On earnings/updates: ALM.SM (Almirall), KNOS.LN (Kainos Group), BELA.GA (Jumbo)

      • Notable Decliners

        • -14.8% LEHN.SW (LEM Holding) -- H1 net income CHF6.8M vs FactSet CHF3.6M [1 est]; guides FY; updates mid-term financial ambitions

        • -11.7% ORY.SM (Oryzon Genomics) -- to hold EGM on 11-Dec; on the agenda, approval of a capital increase of up to €125M, remuneration policy, other

        • -8.0% SL.IM (Sanlorenzo) -- 9M net income €75.9M, +4% vs year-ago €72.9M, reaffirms FY guidance and sharpens target KPIs

        • -4.4% JTC.LN (JTC) -- Permira confirms recommended 1,340p/share in cash offer to acquire JTC

        • -4.3% ENSU.NO (Ensurge Micropower) -- NOK20M repair issue/subsequent offering; NOK100M placement at NOK0.90/share

        • -2.8% APN.LN (Applied Nutrition) -- FY adj. EPS 9.1p vs FactSet 9.1p [5 est, 9.0-9.1p]; Full year expectations for FY26 remain unchanged at this stage

        • -2.1% RMV.LN (Rightmove) -- underweight from equal weight at Barclays; neutral from buy at UBS; buy from hold at Panmure Liberum; outperform from sector perform at RBC Capital Markets

        • -1.5% CHG.LN (Chemring Group) -- FY adj. operating profit is expected to be in-line with analyst expectations, adj EPS is expected to benefit from slightly lower finance costs

        • -1.4% SIGHT.FP (GenSight Biologics) -- completes €2.0M fundraising subscribed by two investors which were existing shareholders Invus and Alumni Capital; extends cash runway to Jan-26

        • -1.3% QBY.GR (q.beyond) -- Q3 net income €0.5M vs year-ago (€0.9M); FY25 revenues now expected at lower end of the €184-190M range; shares reversed modest initial gains

        • -0.8% SAMPO.FH (Sampo) -- market perform from outperform at Keefe, Bruyette & Woods

          • On earnings/updates: reversing initial gains BNOR.LN (BlueNord), HAUTO.NO (Höegh Autoliners)

    • EU companies reporting tomorrow:

      • Earnings:

        • Benelux: Kendrion (KENDR.NA)

        • Denmark: Scandinavian Tobacco Group (STG.DC), Copenhagen Airports (KBHL.DC), H+H International (HH.DC), Jeudan (JDAN.DC)

        • Finland: Mandatum (MANTA.FH), Raisio (RAIVV.FH), Kamux (KAMUX.FH)

        • Germany: Munich Re (MUV2.GR), Fraport (FRA.GR), Porsche Automobil Holding (PAH3.GR), K+S (SDF.GR), United Internet (UTDI.GR), Deutsche Wohnen (DWNI.GR), IONOS Group (IOS.GR), 1&1 (1U1.GR), TAG Immobilien (TEG.GR), Stroeer (SAX.GR), KSB (KSB.GR), Medios (ILM1.GR)

        • Italy: Recordati (REC.IM), A2A (A2A.IM), Italmobiliare (ITM.IM), Philogen (PHIL.IM), doValue (DOV.IM), IGD SIIIQ (IGD.IM), B&C Speakers (BEC.IM), Sabaf (SAB.IM)

        • Norway: Bouvet (BOUV.NO), Salmon Evolution (SALME.NO), Nordhealth (NORDH.NO), Spir Group (SPIR.NO), Webstep (WSTEP.NO), Capsol Technologies (CAPSL.NO)

        • Spain: Vocento (VOC.SM)

        • Sweden: NOBA Bank Group (NOBA.SS), AlzeCure Pharma (ALZCUR.SS), Starbreeze (STAR.B.SS), Vivesto (VIVE.SS), Coinshares International (CS.SS), Bahnhof (BAHN.B.SS), Fasadgruppen Group (FG.SS), Enad Global 7 (EG7.SS)

        • Switzerland: Sunrise Communications (SUNN.SW), PSP Swiss Property (PSPN.SW)

        • UK: Vodafone Group (VOD.LN), DCC (DCC.LN), Air Astana (AIRA.LN), Oxford Instruments (OXIG.LN), Avon Technologies (AVON.LN), AB Dynamics (ABDP.LN), Dialight (DIA.LN)

        • Other: CEZ (CEZ.CP), Bank of Cyprus Holdings (BOCH.CY)

      • Trading Statement:

        • Benelux: TKH Group (TWEKA.NA), B&S Group (BSGR.NA)

      • Traffic: Heathrow Airport (+HTR.LN), Aeroflot-Russian Airline (AFLT.RU)

      • CMD/Events: SKF (SKF.B.SS), Telenor (TEL.NO), Marks & Spencer Group (MKS.LN), Titan (TITC.BB), HENSOLDT (HAG.GR), Orell Füssli (OFN.SW), Heidelberg Pharma (HPHA.GR) R&D

  • Data:

    • Economics:

      • Eurozone Nov Sentix investor confidence (7.4) vs consensus (3.9), prior (5.4)

      • Norway Oct

        • CPI +3.3% y/y vs consensus +3.1%, prior +3.6%

        • PPI (6.9%) y/y vs consensus (2.4%), prior (2.8%)

      • Sweden Sep industrial production +13.5% y/y vs consensus +3.2%, prior revised +10.2% from +10.6%

      • Denmark

        • Oct CPI +2.1% y/y vs consensus +2.3%, prior +2.3%

        • Sep trade balance DKK33.5B vs consensus DKK32.7B, prior prevised DKK25.8B from DKK22.2B

      • Netherlands Sep manufacturing production +0.1% m/m vs consensus (1.5%), prior revised +2.0% from +1.7%

      • Finland Sep industrial production (1.8%) y/y vs consensus +0.9%, prior (0.2%)

      • Greece

        • Oct CPI +2.0% y/y vs consensus +2.1%, prior +1.9%

        • Sep industrial production +6.8% y/y vs consensus +1.6%, prior revised (2.8%) from (2.9%)

    • Markets:

      • WTI Crude (Dec 25): ($0.18) or (0.30%) to $59.57

      • €-$ (0.0011) or (0.10%) to 1.1551

      • £-$ (0.0003) or (0.02%) to 1.3157

      • €-£ (0.0003) to 0.8779

      • S&P 500 +0.70%

      • Performance year-to-date:

        • FTSE 100: +19.75%

        • DAX: +20.35%

        • CAC: +9.14%

        • MIB: +28.40%

        • Stoxx 600: +12.84%

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE